HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hehrlein, F. W. Articles by Boldt, J. Search for Related Content PubMed PubMed Citation Articles by Hehrlein, F. W. Articles by Boldt, J.

The Annals of Thoracic Surgery, Vol 52, 112-117, Copyright © 1991 by The Society of Thoracic Surgeons

ARTICLES

Pediatric heart transplantation for congenital heart disease and cardiomyopathy

FW Hehrlein, H Netz, R Moosdorf, F Dapper, HH Scheld, J Bauer and J Boldt
Department of Cardiovascular Surgery, Justus-Liebig-University, Giessen, Germany.

Orthotopic heart transplantation has become an accepted therapy for adult patients with end-stage heart disease. In newborns and infants, this procedure is still controversial because of the unknown long-term results and the lack of donor organs. Since March 1988, we have performed orthotopic heart transplantation in 11 infants and children with hypoplastic left heart syndrome (n = 6), cardiomyopathy (n = 4), or congenital endocardial fibroelastosis (n = 1). The smallest infant was 3 days old and weighed 2,650 g. Four of 15 potential donors had to be refused for various medical reasons, and 4 were transferred to our hospital for organ retrieval. Seven hearts were procured remotely. We accepted weight mismatches up to 105% between donor and recipient. There were three perioperative deaths, two in patients 5 and 17 days old with hypoplastic left heart syndrome and 1 in a 2-year-old patient with a dilated cardiomyopathy. All 3 patients had drug-resistant right heart failure. A 2-year-old girl with a dilated cardiomyopathy died 2 months after transplantation owing to severe pulmonary embolism originating from the superior vena cava. The remaining 7 patients are alive and well between 1 month and 31 months after transplantation. Angiographic follow-up has not revealed signs of graft atherosclerosis at 2 years.

This article has been cited by other articles:

				K. A. Jayakumar, L. J. Addonizio, M. R. Kichuk-Chrisant, M. E. Galantowicz, J. M. Lamour, J. M. Quaegebeur, and D. T. Hsu Cardiac transplantation after the Fontan or Glenn procedure J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2065 - 2072. [Abstract] [Full Text] [PDF]

				F. Dapper, J. Bauer, J. Kroll, B. Zickmann, R. M. Bohle, K. J. Hagel, and D. Schranz Clinical experience with heart transplantation in infants Eur. J. Cardiothorac. Surg., July 1, 1999; 14(1): 1 - 6. [Abstract] [Full Text] [PDF]